| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.3 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | ML162 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.029 | 0.4 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.4 |
| mRNA | L-685458 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |